Syndicate This week's upcoming IPO's and secondary offerings

Week of October 12 to October 16, 2024

This Week's Deals to be Priced

10/12 - Monday

Symbol

Issuer

Type

Price

Managers

PGNY

Progyny
Progyny
Block Trade
$29.51
3.1M
BofA

Pricing after close

Managers: BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/14 - Wednesday

Symbol

Issuer

Type

Price

Managers

SPEL

Spinal Elements
Spinal Elements
IPO
Postponed $13.00-15.00
7.7M
Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse, Baird & Stifel, Truist, BTIG, SIEB

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/15 - Thursday

Symbol

Issuer

Type

Price

Managers

LAZY

Lazydays
Lazydays
Secondary
Withdrawn $16.80
4M
Baird,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Baird, Craig-Hallum, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

10/12 - Monday

Symbol

Issuer

Type

Price

Managers

RUN

Sunrun
Sunrun
Block Trade
Priced: $62.00
8M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
V

Visa
Visa
Block Trade
Priced: $205.40
2.7M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/13 - Tuesday

Symbol

Issuer

Type

Price

Managers

CDAK

Codiak
Codiak
IPO
Priced: $15.00
5.5M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Evercore ISI & William Blair, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
COLD

Americold Realty Trust
Americold Realty Trust
Secondary
Priced: $38.00
31.9M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, BofA & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RCL

Royal Caribbean
Royal Caribbean
Secondary
Priced: $60.00
8.33M
Morgan Stanley & BofA,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & BofA, Citi, DNBB, Goldman Sachs, HSBC, JPMorgan, SEB Group

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OCUL

Ocular Therapeutix
Ocular Therapeutix
Spot Secondary
Priced: $9.75
7.18M
Jefferies & Piper Sandler

Pricing after close
Deal analysis and details

Managers: Jefferies & Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TACT

TransAct Technologies
TransAct Technologies
Spot Secondary
Priced: $7.10
1.2M
Roth MKM,...

Pricing after close
Deal analysis and details

Managers: Roth MKM, Barrington

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/14 - Wednesday

Symbol

Issuer

Type

Price

Managers

BE

Bloom Energy
Bloom Energy
Block Trade
Priced: $19.45
12.339M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARRY

Array Technologies
Array Technologies
IPO
Priced: $22.00
47.5M
Goldman Sachs & JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs & JPMorgan, Guggenheim, Morgan Stanley, Credit Suisse, Barclays, UBS, TD Cowen, Oppenheimer, MUFG, Nomura

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MNSO

MINISO
MINISO
IPO
Priced: $20.00
30.4M
Goldman Sachs & BofA

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs & BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TMTS

Spartacus Acquisition
Spartacus Acquisition
IPO
Priced: $10.00
25M
B. Riley

Pricing after close

Managers: B. Riley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VVPR

VivoPower
VivoPower
Secondary
Priced: $8.50
2.941M
Maxim

Pricing after close

Managers: Maxim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATEC

Alphatec
Alphatec
Spot Secondary
Priced: $8.75
11.43M
Morgan Stanley & TD Cowen,...

Pre-open pricing
Deal analysis and details

Managers: Morgan Stanley & TD Cowen, Canaccord, LAKE, Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SIBN

SI-Bone
SI-Bone
Spot Secondary
Priced: $22.00
3.19M
Morgan Stanley & BofA,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & BofA, Cantor Fitzgerald, JMP Securities, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/15 - Thursday

Symbol

Issuer

Type

Price

Managers

ALGS

Aligos Therapeutics
Aligos Therapeutics
IPO
Priced: $15.00
10M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Jefferies, Piper Sandler & Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EAR

Eargo
Eargo
IPO
Priced: $18.00
7.85M
JPMorgan & BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan & BofA, Wells Fargo, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KRBP

Kiromic BioPharma
Kiromic BioPharma
IPO
Priced: $12.00
1.25M
ThinkEquity

Pricing after close

Managers: ThinkEquity

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OPT

Opthea
Opthea
IPO
Priced: $13.50
8.563M
Citi & Leerink,...

Pricing after close
Deal analysis and details

Managers: Citi & Leerink, Oppenheimer, Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PRAX

Praxis Precision Meds
Praxis Precision Meds
IPO
Priced: $19.00
10M
TD Cowen,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: TD Cowen, Evercore ISI, Piper Sandler & Wedbush, BLAK

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TARS

Tarsus Pharmaceuticals
Tarsus Pharmaceuticals
IPO
Priced: $16.00
5.5M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Jefferies & Raymond James, LIFE, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RPRX

Royalty Pharma
Royalty Pharma
Secondary
Priced: $42.00
17.3M
JPMorgan,...

Pricing after close

Managers: JPMorgan, Morgan Stanley, BofA, Goldman Sachs & Citi, TD Cowen, Evercore ISI, Truist, UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SPNS

Sapiens
Sapiens
Secondary
Priced: $29.50
3.4M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, JPMorgan, Citi & Jefferies, Needham, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

No Date Assigned

Symbol

Issuer

Type

Price

Managers

ETON

Eton Pharmaceuticals
Eton Pharmaceuticals
Secondary
Priced: $7.00
2.8M
National Securities

Pricing after close
Deal analysis and details

Managers: National Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial

Learn more »